المؤلفون: Demetri, GD, Antonescu, CR, Bjerkehagen, B, Bovée, JVMG, Boye, K, Chacón, M, Dei Tos, AP, Desai, J, Fletcher, JA, Gelderblom, H, George, S, Gronchi, A, Haas, RL, Hindi, N, Hohenberger, P, Joensuu, H, Jones, RL, Judson, I, Kang, YK, Kawai, A, Lazar, AJ, Le Cesne, A, Maestro, R, Maki, RG, Martín, J, Patel, S, Penault-Llorca, F, Premanand Raut, C, Rutkowski, P, Safwat, A, Sbaraglia, M, Schaefer, IM, Shen, L, Serrano, C, Schöffski, P, Stacchiotti, S, Sundby Hall, K, Tap, WD, Thomas, DM, Trent, J, Valverde, C, van der Graaf, WTA, von Mehren, M, Wagner, A, Wardelmann, E, Naito, Y, Zalcberg, J, Blay, JY

المصدر: urn:ISSN:0923-7534 ; urn:ISSN:1569-8041 ; Annals of Oncology, 31, 11, 1506-1517

مصطلحات موضوعية: Cancer, Biotechnology, 4.1 Discovery and preclinical testing of markers and technologies, 4 Detection, screening and diagnosis, 3 Good Health and Well Being, Adult, Gene Fusion, Humans, Oncogene Proteins, Fusion, Protein Kinase Inhibitors, Receptor, trkA, Sarcoma, Tropomyosin, entrectinib, larotrectinib, neurotrophic tyrosine receptor kinase, tropomyosin receptor kinase, anzsrc-for: 1112 Oncology and Carcinogenesis

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/1959.4/unsworks_75834Test; https://unsworks.unsw.edu.au/bitstreams/f43a6893-15e1-4065-a10b-f86a7ab6b158/downloadTest; https://doi.org/10.1016/j.annonc.2020.08.2232Test

الإتاحة: https://doi.org/10.1016/j.annonc.2020.08.2232Test
http://hdl.handle.net/1959.4/unsworks_75834Test
https://unsworks.unsw.edu.au/bitstreams/f43a6893-15e1-4065-a10b-f86a7ab6b158/downloadTest

المؤلفون: Demetri, G. D., Antonescu, C. R., Bjerkehagen, B., Bovee, J. V. M. G., Boye, K., Chacon, M., Dei Tos, A. P., Desai, J., Fletcher, J. A., Gelderblom, H., George, S., Gronchi, A., Haas, R. L., Hindi, N., Hohenberger, P., Joensuu, H., Jones, R. L., Judson, Ian, Kang, Y-K, Kawai, A., Lazar, A. J., Le Cesne, A., Maestro, R., Maki, Rg, Martin, J., Patel, S., Penault-Llorca, F., Raut, C. Premanand, Rutkowski, P., Safwat, A., Sbaraglia, M., Schaefer, I-M, Shen, L., Serrano, C., Schoffski, P., Stacchiotti, S., Hall, K. Sundby, Tap, W. D., Thomas, D. M., Trent, J., Valverde, C., van der Graaf, W. T. A., von Mehren, M., Wagner, A., Wardelmann, E., Naito, Y., Zalcberg, J., Blay, J-Y

المساهمون: Research Programs Unit, Heikki Joensuu / Principal Investigator, HUS Comprehensive Cancer Center, Department of Oncology, Clinicum, Helsinki University Hospital Area

مصطلحات موضوعية: entrectinib, larotrectinib, neurotrophic tyrosine receptor kinase, sarcoma, tropomyosin receptor kinase, GASTROINTESTINAL STROMAL TUMORS, ETV6-NTRK3 GENE FUSION, POSITIVE SOLID TUMORS, NTRK FUSION, CONGENITAL INSENSITIVITY, GROWTH-FACTOR, MUTATIONS, CANCERS, SUBSET, 3122 Cancers

وصف الملف: application/pdf

العلاقة: GDD was supported in part by the Ludwig Center at Harvard; the Dr Miriam and Sheldon G. Adelson Medical Research Foundation; and the Pan Mass Challenge (no grant numbers). IMS is supported by the National Institutes of Health/National Cancer Institute (grant number K08 CA241085). JYB was supported by NetSARC (INCA & DGOS) and RREPS (INCA & DGOS), RESOS (INCA & DGOS), EURACAN (EC 739521), LYRICAN (INCA-DGOS-INSERM 12563), LabEx DEvweCAN (ANR-10-LABX-0061), Institut Convergence PLASCAN (17CONV-0002), RHU4 DEPGYN (ANR-18-RHUS-0009).; Demetri , G D , Antonescu , C R , Bjerkehagen , B , Bovee , J V M G , Boye , K , Chacon , M , Dei Tos , A P , Desai , J , Fletcher , J A , Gelderblom , H , George , S , Gronchi , A , Haas , R L , Hindi , N , Hohenberger , P , Joensuu , H , Jones , R L , Judson , I , Kang , Y-K , Kawai , A , Lazar , A J , Le Cesne , A , Maestro , R , Maki , R , Martin , J , Patel , S , Penault-Llorca , F , Raut , C P , Rutkowski , P , Safwat , A , Sbaraglia , M , Schaefer , I-M , Shen , L , Serrano , C , Schoffski , P , Stacchiotti , S , Hall , K S , Tap , W D , Thomas , D M , Trent , J , Valverde , C , van der Graaf , W T A , von Mehren , M , Wagner , A , Wardelmann , E , Naito , Y , Zalcberg , J & Blay , J-Y 2020 , ' Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas : expert recommendations from the World Sarcoma Network ' , Annals of Oncology , vol. 31 , no. 11 , pp. 1506-1517 . https://doi.org/10.1016/j.annonc.2020.08.2232Test; ORCID: /0000-0003-0281-2507/work/84255589; b9349fb6-a886-49a4-9e24-9cc9773e006d; http://hdl.handle.net/10138/321873Test; 000582637200010

الإتاحة: http://hdl.handle.net/10138/321873Test

المؤلفون: Piotr Rutkowski, David Thomas, Robert G. Maki, Rick L. Haas, Shreyaskumar Patel, Patrick Schöffski, Y-K. Kang, M. von Mehren, K. Sundby Hall, Nadia Hindi, Akira Kawai, Eva Wardelmann, A. J. Lazar, Jonathan A. Fletcher, A. P. Dei Tos, Marta Sbaraglia, Jonathan C. Trent, Kjetil Boye, Roberta Maestro, Anthony D. Wagner, Hans Gelderblom, César Serrano, Inga-Marie Schaefer, Claudia Valverde, Alessandro Gronchi, Bodil Bjerkehagen, Frédérique Penault-Llorca, C. Premanand Raut, Yoichi Naito, W.T.A. van der Graaf, George D. Demetri, Matías Chacón, John Zalcberg, Judith V.M.G. Bovée, William D. Tap, Akmal Safwat, C. R. Antonescu, Suzanne George, Li Shen, Ian Judson, Jayesh Desai, Javier Martin, J.-Y. Blay, Silvia Stacchiotti, A. Le Cesne, Robin L. Jones, Heikki Joensuu, Peter Hohenberger

المساهمون: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER, Institut Català de la Salut, [Demetri GD] Dana-Farber Cancer Institute and Ludwig Center at Harvard Medical School, Boston, USA. [Antonescu CR] Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA. [Bjerkehagen B] Department of Pathology, Oslo University Hospital, Oslo, Norway. [Bovée JVMG] Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. [Boye K] Department of Oncology, Oslo University Hospital, Oslo, Norway. [Chacón M] Oncology Service Chair, Instituto Alexander Fleming, Buenos Aires, Argentina. [Serrano C] Sarcoma Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Valverde C] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Research Programs Unit, Heikki Joensuu / Principal Investigator, HUS Comprehensive Cancer Center, Department of Oncology, Clinicum, Helsinki University Hospital Area, Harvard University, Adelson Medical Research Foundation, National Institutes of Health (US), National Cancer Institute (US)

المصدر: Demetri, G D, Antonescu, C R, Bjerkehagen, B, Bovée, J V M G, Boye, K, Chacón, M, Dei Tos, A P, Desai, J, Fletcher, J A, Gelderblom, H, George, S, Gronchi, A, Haas, R L, Hindi, N, Hohenberger, P, Joensuu, H, Jones, R L, Judson, I, Kang, Y K, Kawai, A, Lazar, A J, Le Cesne, A, Maestro, R, Maki, R G, Martín, J, Patel, S, Penault-Llorca, F, Premanand Raut, C, Rutkowski, P, Safwat, A, Sbaraglia, M, Schaefer, I M, Shen, L, Serrano, C, Schöffski, P, Stacchiotti, S, Sundby Hall, K, Tap, W D, Thomas, D M, Trent, J, Valverde, C, van der Graaf, W T A, von Mehren, M, Wagner, A, Wardelmann, E, Naito, Y, Zalcberg, J & Blay, J Y 2020, ' Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas : expert recommendations from the World Sarcoma Network ', Annals of Oncology, vol. 31, no. 11, pp. 1506-1517 . https://doi.org/10.1016/j.annonc.2020.08.2232Test
Annals of Oncology
Annals of Oncology, Elsevier, 2020, 31 (11), pp.1506-1517. ⟨10.1016/j.annonc.2020.08.2232⟩
Annals of oncology : official journal of the European Society for Medical Oncology
Annals of Oncology, 31, 1506-1517
Scientia
Annals of Oncology, 31, 11, pp. 1506-1517
Annals of Oncology, 31(11), 1506-1517. ELSEVIER
Digital.CSIC. Repositorio Institucional del CSIC
instname

مصطلحات موضوعية: 0301 basic medicine, sarcoma, Oncogene Proteins, Fusion, entrectinib, [SDV]Life Sciences [q-bio], Soft Tissue Neoplasms, Tropomyosin, Disease, Other subheadings::Other subheadings::/drug therapy [Other subheadings], 0302 clinical medicine, CONGENITAL INSENSITIVITY, POSITIVE SOLID TUMORS, larotrectinib, Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma [DISEASES], Molecular pathology, Kinase, GASTROINTESTINAL STROMAL TUMORS, neurotrophic tyrosine receptor kinase, tropomyosin receptor kinase, ETV6-NTRK3 GENE FUSION, Proto-Oncogene Proteins c-mdm2, Hematology, NTRK FUSION, SUBSET, 3. Good health, Oncology, 030220 oncology & carcinogenesis, Immunohistochemistry, Sarcoma, Gene Fusion, neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::sarcoma [ENFERMEDADES], Life Sciences & Biomedicine, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Adult, GROWTH-FACTOR, CANCERS, 3122 Cancers, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors [CHEMICALS AND DRUGS], Article, 03 medical and health sciences, medicine, Humans, Sarcoma - Tractament, Receptor, trkA, Protein Kinase Inhibitors, Gene, Science & Technology, MUTATIONS, acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteínas cinasas [COMPUESTOS QUÍMICOS Y DROGAS], business.industry, Cyclin-Dependent Kinase 4, medicine.disease, Proteïnes quinases - Inhibidors, 030104 developmental biology, Trk receptor, Cancer research, business

وصف الملف: application/pdf; Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc6da2272a91c82fcd7dcaf0bec00d6Test
https://pure.au.dk/portal/da/publications/diagnosis-and-management-of-tropomyosin-receptor-kinase-trk-fusion-sarcomasTest(d4cdbeec-e95a-46e5-9266-9b370d76c19f).html